Cargando…
Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer
The study objective was to assess US physicians’ Mismatch Repair/Microsatellite Instability (MMR/MSI) testing practices for metastatic colorectal cancer (mCRC) patients. A non-interventional, cross-sectional online survey was conducted among 151 physicians (91 oncologists, 15 surgeons and 45 patholo...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518162/ https://www.ncbi.nlm.nih.gov/pubmed/31022981 http://dx.doi.org/10.3390/jcm8040558 |
_version_ | 1783418403934961664 |
---|---|
author | Eriksson, Jennifer Amonkar, Mayur Al-Jassar, Gemma Lambert, Jeremy Malmenäs, Mia Chase, Monica Sun, Lucy Kollmar, Linda Vichnin, Michelle |
author_facet | Eriksson, Jennifer Amonkar, Mayur Al-Jassar, Gemma Lambert, Jeremy Malmenäs, Mia Chase, Monica Sun, Lucy Kollmar, Linda Vichnin, Michelle |
author_sort | Eriksson, Jennifer |
collection | PubMed |
description | The study objective was to assess US physicians’ Mismatch Repair/Microsatellite Instability (MMR/MSI) testing practices for metastatic colorectal cancer (mCRC) patients. A non-interventional, cross-sectional online survey was conducted among 151 physicians (91 oncologists, 15 surgeons and 45 pathologists) treating mCRC patients in the US. Eligible physicians were US-based with at least 5 years of experience treating CRC patients, had at least one mCRC patient in their routine care in the past 6 months, and had ordered at least one MMR/MSI test for CRC in the past 6 months. Descriptive and logistic regression analyses were performed. Awareness of specific MMR/MSI testing guidelines was high (n = 127, 84.1%). Of those, 93.7% (119/127) physicians had awareness of specific published guidelines with majority 67.2% (80/119) being aware of National Comprehensive Cancer Network (NCCN) guidelines. Universal testing for all CRC patients was performed by 68.9% (104/151) physicians, while 29.8% (45/151) selectively order the test for some CRC patients. Key barriers for testing included insufficient tissue sample (48.3%, 73/151), patient declined to have the test done (35.8%, 54/151) and insurance cost concerns for patients (31.1%, 47/151), while 27.2% (41/151) reported no barriers. The survey demonstrated high awareness and compliance with MMR/MSI testing guidelines although universal testing rates seem to be suboptimal. |
format | Online Article Text |
id | pubmed-6518162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65181622019-05-31 Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer Eriksson, Jennifer Amonkar, Mayur Al-Jassar, Gemma Lambert, Jeremy Malmenäs, Mia Chase, Monica Sun, Lucy Kollmar, Linda Vichnin, Michelle J Clin Med Article The study objective was to assess US physicians’ Mismatch Repair/Microsatellite Instability (MMR/MSI) testing practices for metastatic colorectal cancer (mCRC) patients. A non-interventional, cross-sectional online survey was conducted among 151 physicians (91 oncologists, 15 surgeons and 45 pathologists) treating mCRC patients in the US. Eligible physicians were US-based with at least 5 years of experience treating CRC patients, had at least one mCRC patient in their routine care in the past 6 months, and had ordered at least one MMR/MSI test for CRC in the past 6 months. Descriptive and logistic regression analyses were performed. Awareness of specific MMR/MSI testing guidelines was high (n = 127, 84.1%). Of those, 93.7% (119/127) physicians had awareness of specific published guidelines with majority 67.2% (80/119) being aware of National Comprehensive Cancer Network (NCCN) guidelines. Universal testing for all CRC patients was performed by 68.9% (104/151) physicians, while 29.8% (45/151) selectively order the test for some CRC patients. Key barriers for testing included insufficient tissue sample (48.3%, 73/151), patient declined to have the test done (35.8%, 54/151) and insurance cost concerns for patients (31.1%, 47/151), while 27.2% (41/151) reported no barriers. The survey demonstrated high awareness and compliance with MMR/MSI testing guidelines although universal testing rates seem to be suboptimal. MDPI 2019-04-24 /pmc/articles/PMC6518162/ /pubmed/31022981 http://dx.doi.org/10.3390/jcm8040558 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Eriksson, Jennifer Amonkar, Mayur Al-Jassar, Gemma Lambert, Jeremy Malmenäs, Mia Chase, Monica Sun, Lucy Kollmar, Linda Vichnin, Michelle Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer |
title | Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer |
title_full | Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer |
title_fullStr | Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer |
title_full_unstemmed | Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer |
title_short | Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal Cancer |
title_sort | mismatch repair/microsatellite instability testing practices among us physicians treating patients with advanced/metastatic colorectal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518162/ https://www.ncbi.nlm.nih.gov/pubmed/31022981 http://dx.doi.org/10.3390/jcm8040558 |
work_keys_str_mv | AT erikssonjennifer mismatchrepairmicrosatelliteinstabilitytestingpracticesamongusphysicianstreatingpatientswithadvancedmetastaticcolorectalcancer AT amonkarmayur mismatchrepairmicrosatelliteinstabilitytestingpracticesamongusphysicianstreatingpatientswithadvancedmetastaticcolorectalcancer AT aljassargemma mismatchrepairmicrosatelliteinstabilitytestingpracticesamongusphysicianstreatingpatientswithadvancedmetastaticcolorectalcancer AT lambertjeremy mismatchrepairmicrosatelliteinstabilitytestingpracticesamongusphysicianstreatingpatientswithadvancedmetastaticcolorectalcancer AT malmenasmia mismatchrepairmicrosatelliteinstabilitytestingpracticesamongusphysicianstreatingpatientswithadvancedmetastaticcolorectalcancer AT chasemonica mismatchrepairmicrosatelliteinstabilitytestingpracticesamongusphysicianstreatingpatientswithadvancedmetastaticcolorectalcancer AT sunlucy mismatchrepairmicrosatelliteinstabilitytestingpracticesamongusphysicianstreatingpatientswithadvancedmetastaticcolorectalcancer AT kollmarlinda mismatchrepairmicrosatelliteinstabilitytestingpracticesamongusphysicianstreatingpatientswithadvancedmetastaticcolorectalcancer AT vichninmichelle mismatchrepairmicrosatelliteinstabilitytestingpracticesamongusphysicianstreatingpatientswithadvancedmetastaticcolorectalcancer |